The global drug industry has fought to prevent developing nations from making low-cost, generic versions of drugs under patent, but the demand for such alternatives is could rise with increasing ...

Generic drugs are the rare part of American health care that actually drives down costs. In 2024, they accounted for 90 ...

You’d think companies would want their products’ names to be memorable, catchy and descriptive: Windex, Duracell, KitchenAid. So why has Big Pharma been doing the exact opposite for the past few years ...

Yue Guan of Wanhuida Intellectual Property explains how the CNIPA’s rulings on mirogabalin besylate tablets highlight the importance of formulation patent drafting and claim amendments in China’s drug ...

Dozens of companies have pledged to build more manufacturing in the U.S. since President Trump took office. Generic drugmakers aren’t among them. And they have no plans to change that anytime soon.

Generic drugmakers continue to face mounting pressure not only from pricing competition but also from Trump’s push for pharmaceutical import tariffs and the proposed “most-favored-nation” pricing ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

Add Yahoo as a preferred source to see more of our stories on Google. In December of 2007, LeRoy Hubley endured the most devastating experience of his life. His wife of 48 years and his son died ...

Artificial Intelligence–Based Digital Histologic Classifier for Prostate Cancer Risk Stratification: Independent Blinded Validation in Patients Treated With Radical Prostatectomy This study evaluated ...

The post “A Godsend”: ProPublica’s Rx Inspector Tool Is Helping People Find Critical Safety Information on Generic Drugs ...